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Identity 
Other names: CTLA3, HFSP 
HGNC (Hugo): GZMA 
Location: 5q11.2 
Local order: Size: 7607 bases. Coordinates: 54398473. 
DNA/RNA 
Description 
The GZMA gene, with 7607 bases in length, consists of 
5 exons and 4 introns. GZMA gene is located in a gene 
cluster together with granzyme K (figure 1) (Grossman 
et al., 2003). 
Transcription 
There are at least two transcripts of human GZMA 
whose expression is differentially regulated by 
glucocorticoid (Ruike et al., 2007). These transcripts 
generate two isoforms, GZMAα and GZMAβ, which 
have respective first exons: exon 1a and exon 1b 
(figure 1): 
GZMAα (exon 1a): canonical sequence, 
GZMAβ (exon 1b): lack aa 1-17; aa 18-23 LLLIPE --> 
MTKGLR. 
 
Figure 1. Genomic organization of human GZMA. A, human GZMA cluster. Arrow indicate the direction of transcription. B, 
representation of the GZMA genetic locus. White: untranslated regions; Blue: leader sequence; Green: mature enzyme. Solid lanes: 
splicing between the first and second exons. gre: glucocorticoid response element (adapted from Ruike et al., 2007). 
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Figure 2. Diagram of the crystal structure of human granzyme A dimer (Bell et al., 2003; Hink-Schauer et al., 2003). The cystein 
groups involved in disulphide bond-mediated dimer (green) and the three aminoacids forming the catalytic triad (red, blue and yellow) are 
shown. Representation from PDB (accession code 1OP8) deposited by Hink-Schauer C, Estébanez-Perpiñá E, Kurschus FC, Bode W, 




Granzyme A is a tryptase (cleave proteins after Lys or 
Arg residues) expressed mainly in cytotoxic cells 
(cytotoxic T and Natural Killer cells) (Masson et al., 
1986; Simon et al., 1986; Young et al., 1986). Protein 
is expressed as a preproenzyme (Jenne et al., 1988) 
containing a signal sequence that mediates targeting of 
the nascent enzyme to the ER. Cleavage of the signal 
peptide produces an inactive proenzyme that contains 
an N-terminal dipeptide that needs to be cleaved to 
produce an active protease. In the Golgi, a mannose-6-
phosphate tag is added for transporting the proenzyme 
to cytotoxic granules. Within the cytotoxic granule, the 
N-terminal dipeptide is removed by cathepsin C 
(dipeptidyl peptidase I) (Pham et al., 1999), producing 
the active enzyme that is kept inactive at low pH. 
Native granzyme A is expressed as a dimer (Bell et al., 
2003; Hink-Schauer et al., 2003). 
Expression 
Cytotoxic CD8+ T cells, Natural Killer cells, CD4+ T 
cells, gamma-delta T cells, type II pneumocytes, 




Granzyme A is delivered from CTL or NK cytotoxic 
granules to the cytoplasm of target cell by a mechanism 
dependent on perforin (Baran et al., 2009; Praper et al., 
2011; Thiery et al., 2011). 
There are some controversial findings about the 
physiological function of gzmA. 
It has been reported that human GzmA induces 
perforin-mediated caspase-independent cell death in 
some tumors cell lines (Hayes et al., 1989; Shi et al., 
1992; Beresford et al., 1999; Shresta et al., 1999; Pardo 
et al., 2004). GzmA translocates to the nucleus and 
mitochondria where key substrates such as 
mitochondrial complex I protein, NADH 
dehydrogenase Fe-S protein 3 (NDUFS3) is cleaved, 
inducing the production of Radical Oxygen Species 
(ROS). ROS production induces the activation of the 
SET complex that translocates into the nucleus in order 
to repair DNA damage induced by ROS. Once there, 
granzyme A cleaves components of the endoplasmic 
reticulum-associated SET complex, releasing the 
endonuclease NM23H1 that induces single strand nicks 
in the DNA and ultimately cell death (Lieberman, 
2011). 
Other authors have reported that the cytotoxic potential 
of granzyme A is low, but induce expression of pro-
inflammatory cytokines in monocytes-like cells by a 
caspase-1 dependent mechanism (Metkar et al., 2008). 
Granzyme A is able to cleave several extracellular 
substrates like thrombin receptor, fibronectin, collagen 
IV, proteinase-activated receptor-2, Pro-urokinase 
plasminogen activator and myelin basic protein 
(Kramer et al., 1987; Buzza et al., 2006; Hendel et al., 
2011). 
Granzyme and granzyme B double deficient mice are 
more susceptible than granzyme B deficient mice to 
transplanted tumors suggesting a contribution of 
granzyme A to tumor control in vivo (Pardo et al., 
2002; Cao et al., 2007). 
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Homology 
Mouse granzyme A; Rat granzyme A; Chicken 
granzyme A; Fish granzyme A (Common Carp, 
Atlantic cod, Channel catfish) (Praveen et al., 2006; 
Praveen et al., 2006; Wernersson et al., 2006). 
Mutations 
Note: Not known. 
Implicated in 
Sepsis (Froelich et al., 2009; Hendel et al., 2011) 
Disease 
Several findings suggest that gzmA contributes to 
septic shock. Native and recombinant human granzyme 
A as well as a human NK cell line expressing gzmA 
induces human adherent peripheral blood mononuclear 
cells to express proinflammatory cytokines including 
interleukin-1beta interleukin-6, inteleukin-8 and TNF-
alpha (Sower et al., 1996; Metkar et al., 2008). 
Granzyme A deficient mice are more resistant than 
wild type mice to septic shock induced by LPS (Metkar 
et al., 2008). 
Rheumatoid arthritis 
Prognosis 
Granzyme A levels are higher in serum and synovial 
fluid of patients with rheumatoid arthritis (Griffiths et 
al., 1992; Nordstrom et al., 1992; Kummer et al., 1994; 
Tak et al., 1994; Muller-Ladner et al., 1995; Spaeny-
Dekking et al., 1998; Tak et al., 1999). 
Chronic obstructive pulmonary disease 
Prognosis 
Granzyme A is expressed in type II pneumocytes of 
patients with severe chronic obstructive pulmonary 
disease (Vernooy et al., 2007). 
Hypersensitivity pneumonitis 
Prognosis 
Granzyme A is elevated in bronchoalveolar lavage 
fluid from patients with hypersensitivity pneumonitis 
(Tremblay et al., 2000). 
Sjögren's syndrome 
Prognosis 
Granzyme A is expressed in salivary glands from 
patients with Sjögren's syndrome (Alpert et al., 1994). 
Poxvirus infection 
Disease 
Granzyme A deficient mice are more susceptible than 
wild type mice to mousepox virus (ectromelia) 
(Mullbacher et al., 1996). 
Herpes virus infection 
Disease 
Granzyme A deficient mice are more susceptible than 
wild type mice to herpes simplex virus type 1 (HSV-1) 
(Pereira et al., 2000) and mouse cytomegalovirus 
(CMV) infection (Riera et al., 2000). 
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